Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

'I saw it on Facebook!' Assessing the influence of social media on patient presentation to a melanoma screening clinic.

Guckian J, Jobling K, Oliphant T, Weatherhead S, Blasdale K.

Clin Exp Dermatol. 2019 Sep 21. doi: 10.1111/ced.14100. [Epub ahead of print]

PMID:
31541480
2.

Use of a Proximal Peng Flap for Reconstruction of the Nasal Dorsum in 14 Patients.

Jayasekera PSA, Hackett C, Oliphant T, Langtry JAA.

Dermatol Surg. 2019 Dec;45(12):1704-1706. doi: 10.1097/DSS.0000000000001966. No abstract available.

PMID:
31205140
3.

Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.

Bernstein DI, Flechtner JB, McNeil LK, Heineman T, Oliphant T, Tasker S, Wald A, Hetherington S; Genocea study group.

Vaccine. 2019 Jun 6;37(26):3443-3450. doi: 10.1016/j.vaccine.2019.05.009. Epub 2019 May 15.

PMID:
31103365
4.

The causes of nail apparatus pigmentation presenting to a melanoma screening clinic a prospective study.

Alani A, Blasdale C, Oliphant T, Hackett C, Langtry JAA.

Clin Exp Dermatol. 2019 Aug;44(6):625-630. doi: 10.1111/ced.13897. Epub 2019 Jan 31.

PMID:
30706554
5.

Squamous Cell Carcinoma and Multiple Familial Trichoepitheliomas: A Recurrent Association.

Dubois A, Mestre T, Oliphant T, Husain A, Rajan N.

Acta Derm Venereol. 2018 Oct 10;98(9):910-911. doi: 10.2340/00015555-2988. No abstract available.

6.

Squamous cell carcinomas in linear epidermal naevi.

Dubois A, Rannan-Eliya S, Husain A, Rajan N, Oliphant T.

Clin Exp Dermatol. 2019 Mar;44(2):238-240. doi: 10.1111/ced.13704. Epub 2018 Jun 28. No abstract available.

7.

Linear erythronychia with a nick in the free edge of the nail.

Lockwood KA, Oliphant T, Husain A.

Clin Exp Dermatol. 2018 Aug;43(6):725-726. doi: 10.1111/ced.13560. Epub 2018 May 27. No abstract available.

PMID:
29806121
8.

A botanically derived skin surface lipid mimetic based on the composition of healthy 22-year-old females.

Addy J, Oliphant T, Harper R.

J Cosmet Sci. 2017 Jan/Feb;68(1):59-67.

PMID:
29465384
9.

Dystrophic calcinosis cutis within burns, successfully treated with excision and secondary intention wound healing.

Lockwood KA, Oliphant T.

Clin Exp Dermatol. 2018 Jul;43(5):648-649. doi: 10.1111/ced.13396. Epub 2018 Feb 12. No abstract available.

PMID:
29430689
10.

Score and shave technique with freehand scalpel for harvesting small split-thickness skin grafts in dermatological surgery.

Jayasekera PSA, Oliphant T, Langtry JAA.

Clin Exp Dermatol. 2018 Apr;43(3):369-371. doi: 10.1111/ced.13319. Epub 2017 Dec 12. No abstract available.

PMID:
29230858
11.

Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer.

Gebremeskel S, Lobert L, Tanner K, Walker B, Oliphant T, Clarke LE, Dellaire G, Johnston B.

Cancer Immunol Res. 2017 Dec;5(12):1086-1097. doi: 10.1158/2326-6066.CIR-17-0229. Epub 2017 Oct 20.

12.

An Unusual Periungual Lesion.

Jayasekera PSA, Charlton F, Oliphant TJ.

Skin Appendage Disord. 2017 Aug;3(3):129-131. doi: 10.1159/000462982. Epub 2017 Apr 1. Review. No abstract available.

13.

Dermoscopy prior to Mohs micrographic surgery does not improve tumour margin assessment and leads to fewer Mohs stages.

Jayasekera PSA, Dodd J, Oliphant T, Langtry JAA, Lawrence CM.

Br J Dermatol. 2018 Feb;178(2):565-566. doi: 10.1111/bjd.15903. Epub 2017 Dec 26. No abstract available.

PMID:
28851098
14.

Safety, complications and patients' acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group.

Hussain W, Affleck A, Al-Niaimi F, Cooper A, Craythorne E, Fleming C, Ghura V, Langtry J, Lawrence C, Loghdey S, Naysmith L, Oliphant T, Rahim R, Rice S, Sivaramkrishan M, Stables G, Varma S, Mallipeddi R.

Br J Dermatol. 2017 Mar;176(3):806-808. doi: 10.1111/bjd.14843. Epub 2017 Feb 22. No abstract available.

PMID:
27377192
15.

Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management.

Verykiou S, Oliphant TJ, Rahim R, Husain A, Lawrence CM, Langtry JA.

Br J Dermatol. 2016 Mar;174(3):649-51. doi: 10.1111/bjd.14186. Epub 2015 Dec 12. No abstract available.

PMID:
26399472
16.

Successful treatment of forehead lipoma depends on knowledge of the surgical anatomy: a step-by-step guide.

Brass D, Oliphant TJ, McHanwell S, Alexander M, Langtry JA.

Clin Exp Dermatol. 2016 Jan;41(1):3-7. doi: 10.1111/ced.12741. Epub 2015 Aug 26. Review.

PMID:
26307428
17.

The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor.

Garceau V, Balic A, Garcia-Morales C, Sauter KA, McGrew MJ, Smith J, Vervelde L, Sherman A, Fuller TE, Oliphant T, Shelley JA, Tiwari R, Wilson TL, Chintoan-Uta C, Burt DW, Stevens MP, Sang HM, Hume DA.

BMC Biol. 2015 Feb 19;13:12. doi: 10.1186/s12915-015-0121-9.

18.

Serum 25-hydroxyvitamin D levels in patients with atopic eczema and the influence of narrowband ultraviolet B phototherapy.

Rose RF, Williams C, Oliphant T, Browne F, Turner D, Goulden V.

Photodermatol Photoimmunol Photomed. 2014 Dec;30(6):287-93.

PMID:
25574537
19.

Nasal anatomy for the dermatological surgeon.

Oliphant TJ, Langtry JA.

Br J Dermatol. 2014 Sep;171 Suppl 2:2-6. doi: 10.1111/bjd.13071.

PMID:
25124307
20.

Motor nerves of the head and neck that are susceptible to damage during dermatological surgery.

Brown SM, Oliphant T, Langtry J.

Clin Exp Dermatol. 2014 Aug;39(6):677-82; quiz 681-2. doi: 10.1111/ced.12374. Review.

PMID:
25039591
21.

Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor.

Gow DJ, Sauter KA, Pridans C, Moffat L, Sehgal A, Stutchfield BM, Raza S, Beard PM, Tsai YT, Bainbridge G, Boner PL, Fici G, Garcia-Tapia D, Martin RA, Oliphant T, Shelly JA, Tiwari R, Wilson TL, Smith LB, Mabbott NA, Hume DA.

Mol Ther. 2014 Sep;22(9):1580-92. doi: 10.1038/mt.2014.112. Epub 2014 Jun 25.

22.

In vitro functional characterization of feline IgGs.

Strietzel CJ, Bergeron LM, Oliphant T, Mutchler VT, Choromanski LJ, Bainbridge G.

Vet Immunol Immunopathol. 2014 Apr 15;158(3-4):214-23. doi: 10.1016/j.vetimm.2014.01.012. Epub 2014 Feb 5.

PMID:
24560097
23.

A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects.

Henderson LW, Dittrich HC, Strickland A, Blok TM, Newman R, Oliphant T, Albrecht D.

BMC Pharmacol Toxicol. 2014 Jan 25;15:2. doi: 10.1186/2050-6511-15-2.

24.

Resolution of pancreatic panniculitis following metastasectomy.

Banfill KE, Oliphant TJ, Prasad KR.

Clin Exp Dermatol. 2012 Jun;37(4):440-1. doi: 10.1111/j.1365-2230.2011.04237.x. No abstract available.

PMID:
22582914
25.

Calciphylaxis with normal renal function: treated with intravenous sodium thiosulfate.

Smith VM, Oliphant T, Shareef M, Merchant W, Wilkinson SM.

Clin Exp Dermatol. 2012 Dec;37(8):874-8. doi: 10.1111/j.1365-2230.2012.04350.x. Epub 2012 Apr 30.

PMID:
22548382
26.

Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity.

Fisher TS, Kamperschroer C, Oliphant T, Love VA, Lira PD, Doyonnas R, Bergqvist S, Baxi SM, Rohner A, Shen AC, Huang C, Sokolowski SA, Sharp LL.

Cancer Immunol Immunother. 2012 Oct;61(10):1721-33. Epub 2012 Mar 11.

PMID:
22406983
27.

Contact allergy to sodium sulfite and its relationship to sodium metabisulfite.

Oliphant T, Mitra A, Wilkinson M.

Contact Dermatitis. 2012 Mar;66(3):128-30. doi: 10.1111/j.1600-0536.2011.02029.x.

PMID:
22320666
28.

Extensive bilateral leg ulceration.

Oliphant TJ, May K, Morris AD, Holt PJ.

Clin Exp Dermatol. 2012 Oct;37(7):806-7. doi: 10.1111/j.1365-2230.2011.04255.x. Epub 2012 Feb 2. No abstract available.

PMID:
22300006
29.

Allergic contact dermatitis caused by 2,2'-azobis(2-methylpropion-amidine) dihydrochloride used in the manufacture of acrylic polymers.

Oliphant T, Wilkinson M, Wright A.

Contact Dermatitis. 2011 Jun;64(6):356-7. doi: 10.1111/j.1600-0536.2011.01892.x. No abstract available.

PMID:
21564127
30.

Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding.

Lightle S, Aykent S, Lacher N, Mitaksov V, Wells K, Zobel J, Oliphant T.

Protein Sci. 2010 Apr;19(4):753-62. doi: 10.1002/pro.352.

31.

Informing evidence: claimsmaking in midwives' and clients' talk about interventions.

McKenzie PJ, Oliphant T.

Qual Health Res. 2010 Jan;20(1):29-41. doi: 10.1177/1049732309355591. Epub 2009 Nov 25.

PMID:
19940086
32.

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E.

J Immunol. 2009 Jul 1;183(1):650-60. doi: 10.4049/jimmunol.0900093. Epub 2009 Jun 17.

33.

Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.

Zhang S, Vogt MR, Oliphant T, Engle M, Bovshik EI, Diamond MS, Beasley DW.

J Infect Dis. 2009 Jul 15;200(2):202-5. doi: 10.1086/599794.

34.

Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.

Vogt MR, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS.

J Virol. 2009 Jul;83(13):6494-507. doi: 10.1128/JVI.00286-09. Epub 2009 Apr 22.

35.

The host immunologic response to West Nile encephalitis virus.

Diamond MS, Mehlhop E, Oliphant T, Samuel MA.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3024-34. Review.

PMID:
19273254
36.

Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.

Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC.

PLoS Pathog. 2008 May 9;4(5):e1000060. doi: 10.1371/journal.ppat.1000060.

37.

Fast nonlinear image reconstruction for scanning impedance imaging.

Liu H, Hawkins AR, Schultz SM, Oliphant TE.

IEEE Trans Biomed Eng. 2008 Mar;55(3):970-7. doi: 10.1109/TBME.2007.905485.

PMID:
18334388
38.

The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, Diamond MS.

Cell Host Microbe. 2007 Apr 19;1(2):135-45.

39.

A fast linear reconstruction method for scanning impedance imaging.

Liu H, Hawkins AR, Schultz SM, Oliphant TE.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:4277-80.

PMID:
17946235
40.

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.

41.

Induction of epitope-specific neutralizing antibodies against West Nile virus.

Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS.

J Virol. 2007 Nov;81(21):11828-39. Epub 2007 Aug 22.

42.

The molecular basis of antibody-mediated neutralization of West Nile virus.

Oliphant T, Diamond MS.

Expert Opin Biol Ther. 2007 Jun;7(6):885-92. Review.

PMID:
17555373
43.

Modelling for scanning impedance imaging.

Liu H, Hawkins A, Schultz S, Oliphant T.

Conf Proc IEEE Eng Med Biol Soc. 2005;3:2656-9.

PMID:
17282785
44.

Non-contact scanning electrical impedance imaging.

Liu H, Hawkins A, Schultz S, Oliphant T.

Conf Proc IEEE Eng Med Biol Soc. 2004;2:1306-9.

PMID:
17271931
45.

Noncontact scanning electrical impedance imaging.

Liu H, Hawkins A, Schultz S, Oliphant TE.

Conf Proc IEEE Eng Med Biol Soc. 2004;2:1306-9.

PMID:
17271930
46.

Simple linear models of scanning impedance imaging for fast reconstruction of relative conductivity of biological samples.

Oliphant TE, Liu H, Hawkins AR, Schultz SM.

IEEE Trans Biomed Eng. 2006 Nov;53(11):2323-32.

PMID:
17073338
47.

Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.

Jobes DV, Daoust M, Nguyen VT, Padua A, Sinangil F, Pérez-Losada M, Crandall KA, Oliphant T, Posada D, Rambaut A, Fuchs J, Berman PW.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):968-78. Erratum in: AIDS Res Hum Retroviruses. 2007 Jan;23(1):181.

48.

Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, Marri A, Lachmi BE, Olshevsky U, Fremont DH, Pierson TC, Diamond MS.

J Virol. 2006 Dec;80(24):12149-59. Epub 2006 Oct 11.

49.

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.

Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E.

J Virol. 2005 Dec;79(23):14606-13.

50.

Structural basis of West Nile virus neutralization by a therapeutic antibody.

Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH.

Nature. 2005 Sep 29;437(7059):764-9.

PMID:
16193056

Supplemental Content

Loading ...
Support Center